{"id":9889,"date":"2026-07-27T22:29:13","date_gmt":"2026-07-28T03:29:13","guid":{"rendered":"https:\/\/fifarma.org\/?post_type=publicaciones&#038;p=9889"},"modified":"2026-11-04T20:55:10","modified_gmt":"2026-11-05T01:55:10","slug":"fifarma-patient-wait-indicator-2026","status":"publish","type":"publicaciones","link":"https:\/\/fifarma.org\/pt\/publicaciones\/fifarma-patient-wait-indicator-2026\/","title":{"rendered":"FIFARMA Patient W.A.I.T. Indicator 2026 (ENG)"},"content":{"rendered":"<p class=\"wp-block-paragraph\">This report, developed by FIFARMA in collaboration with IQVIA, analyzes access to innovative medicines in Latin America and the main barriers influencing their availability. The study shows that, on average, patients wait 5.7 years from the global approval of an innovative therapy until it becomes available. Based on the analysis of 447 innovative molecules approved between 2014 and 2025 in ten countries across the region, the report identifies opportunities to improve access and strengthen health systems in the face of innovation.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-7387b849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"> \n<div data-block=\"gutenkit\/button\" data-post-id=\"9889\" id=\"block-821f341e-9021-46d5-b2b8-f5daec15cca1\" class=\"wp-block-gutenkit-button gkit15cca1 gutenkit-block\"><div class=\"gkit-btn-wraper\"><a class=\"gkit-btn\" href=\"https:\/\/fifarma.org\/wp-content\/uploads\/2026\/08\/EN-IQVIA_FIFARMA_WAIT_Root_Causes_2026_Full_Report_Updated.pdf\"><div class=\"icon-left\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewbox=\"0 0 512 512\" class=\"gkit-icon\"><path d=\"M0 64C0 28.7 28.7 0 64 0H224V128c0 17.7 14.3 32 32 32H384V304H176c-35.3 0-64 28.7-64 64V512H64c-35.3 0-64-28.7-64-64V64zm384 64H256V0L384 128zM176 352h32c30.9 0 56 25.1 56 56s-25.1 56-56 56H192v32c0 8.8-7.2 16-16 16s-16-7.2-16-16V448 368c0-8.8 7.2-16 16-16zm32 80c13.3 0 24-10.7 24-24s-10.7-24-24-24H192v48h16zm96-80h32c26.5 0 48 21.5 48 48v64c0 26.5-21.5 48-48 48H304c-8.8 0-16-7.2-16-16V368c0-8.8 7.2-16 16-16zm32 128c8.8 0 16-7.2 16-16V400c0-8.8-7.2-16-16-16H320v96h16zm80-112c0-8.8 7.2-16 16-16h48c8.8 0 16 7.2 16 16s-7.2 16-16 16H448v32h32c8.8 0 16 7.2 16 16s-7.2 16-16 16H448v48c0 8.8-7.2 16-16 16s-16-7.2-16-16V432 368z\"\/><\/svg><\/div>Latin America Report<\/a><\/div><\/div>\n \n\n \n<div data-block=\"gutenkit\/button\" data-post-id=\"9889\" id=\"block-f519c89a-c18b-4593-beac-5a95ef11a801\" class=\"wp-block-gutenkit-button gkit11a801 gutenkit-block\"><div class=\"gkit-btn-wraper\"><a class=\"gkit-btn\" href=\"https:\/\/fifarma.org\/wp-content\/uploads\/2026\/10\/EN-CR-IQVIA_FIFARMA_WAIT_2026_Country_Reports.pdf\"><div class=\"icon-left\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewbox=\"0 0 512 512\" class=\"gkit-icon\"><path d=\"M0 64C0 28.7 28.7 0 64 0H224V128c0 17.7 14.3 32 32 32H384V304H176c-35.3 0-64 28.7-64 64V512H64c-35.3 0-64-28.7-64-64V64zm384 64H256V0L384 128zM176 352h32c30.9 0 56 25.1 56 56s-25.1 56-56 56H192v32c0 8.8-7.2 16-16 16s-16-7.2-16-16V448 368c0-8.8 7.2-16 16-16zm32 80c13.3 0 24-10.7 24-24s-10.7-24-24-24H192v48h16zm96-80h32c26.5 0 48 21.5 48 48v64c0 26.5-21.5 48-48 48H304c-8.8 0-16-7.2-16-16V368c0-8.8 7.2-16 16-16zm32 128c8.8 0 16-7.2 16-16V400c0-8.8-7.2-16-16-16H320v96h16zm80-112c0-8.8 7.2-16 16-16h48c8.8 0 16 7.2 16 16s-7.2 16-16 16H448v32h32c8.8 0 16 7.2 16 16s-7.2 16-16 16H448v48c0 8.8-7.2 16-16 16s-16-7.2-16-16V432 368z\"\/><\/svg><\/div>Costa Rica<\/a><\/div><\/div>\n <\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"> \n<div data-block=\"gutenkit\/button\" data-post-id=\"9889\" id=\"block-b4b5128c-1e38-419d-8a9e-82497cc5320b\" class=\"wp-block-gutenkit-button gkitc5320b gutenkit-block\"><div class=\"gkit-btn-wraper\"><a class=\"gkit-btn\" href=\"https:\/\/fifarma.org\/wp-content\/uploads\/2026\/10\/EN-PA-IQVIA_FIFARMA_WAIT_2026_Country_Reports.pdf\"><div class=\"icon-left\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewbox=\"0 0 512 512\" class=\"gkit-icon\"><path d=\"M0 64C0 28.7 28.7 0 64 0H224V128c0 17.7 14.3 32 32 32H384V304H176c-35.3 0-64 28.7-64 64V512H64c-35.3 0-64-28.7-64-64V64zm384 64H256V0L384 128zM176 352h32c30.9 0 56 25.1 56 56s-25.1 56-56 56H192v32c0 8.8-7.2 16-16 16s-16-7.2-16-16V448 368c0-8.8 7.2-16 16-16zm32 80c13.3 0 24-10.7 24-24s-10.7-24-24-24H192v48h16zm96-80h32c26.5 0 48 21.5 48 48v64c0 26.5-21.5 48-48 48H304c-8.8 0-16-7.2-16-16V368c0-8.8 7.2-16 16-16zm32 128c8.8 0 16-7.2 16-16V400c0-8.8-7.2-16-16-16H320v96h16zm80-112c0-8.8 7.2-16 16-16h48c8.8 0 16 7.2 16 16s-7.2 16-16 16H448v32h32c8.8 0 16 7.2 16 16s-7.2 16-16 16H448v48c0 8.8-7.2 16-16 16s-16-7.2-16-16V432 368z\"\/><\/svg><\/div>Panama<\/a><\/div><\/div>\n \n\n \n<div data-block=\"gutenkit\/button\" data-post-id=\"9889\" id=\"block-563693f4-fe4a-48ef-9203-da42407338cf\" class=\"wp-block-gutenkit-button gkit7338cf gutenkit-block\"><div class=\"gkit-btn-wraper\"><a class=\"gkit-btn\" href=\"https:\/\/fifarma.org\/wp-content\/uploads\/2026\/10\/EN-CH-IQVIA_FIFARMA_WAIT_2026_Country_Reports.pdf\"><div class=\"icon-left\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewbox=\"0 0 512 512\" class=\"gkit-icon\"><path d=\"M0 64C0 28.7 28.7 0 64 0H224V128c0 17.7 14.3 32 32 32H384V304H176c-35.3 0-64 28.7-64 64V512H64c-35.3 0-64-28.7-64-64V64zm384 64H256V0L384 128zM176 352h32c30.9 0 56 25.1 56 56s-25.1 56-56 56H192v32c0 8.8-7.2 16-16 16s-16-7.2-16-16V448 368c0-8.8 7.2-16 16-16zm32 80c13.3 0 24-10.7 24-24s-10.7-24-24-24H192v48h16zm96-80h32c26.5 0 48 21.5 48 48v64c0 26.5-21.5 48-48 48H304c-8.8 0-16-7.2-16-16V368c0-8.8 7.2-16 16-16zm32 128c8.8 0 16-7.2 16-16V400c0-8.8-7.2-16-16-16H320v96h16zm80-112c0-8.8 7.2-16 16-16h48c8.8 0 16 7.2 16 16s-7.2 16-16 16H448v32h32c8.8 0 16 7.2 16 16s-7.2 16-16 16H448v48c0 8.8-7.2 16-16 16s-16-7.2-16-16V432 368z\"\/><\/svg><\/div>Chile<\/a><\/div><\/div>\n <\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"> \n<div data-block=\"gutenkit\/button\" data-post-id=\"9889\" id=\"block-6b49ec6d-570e-4425-b652-3a2a79770eb6\" class=\"wp-block-gutenkit-button gkit770eb6 gutenkit-block\"><div class=\"gkit-btn-wraper\"><a class=\"gkit-btn\" href=\"https:\/\/fifarma.org\/wp-content\/uploads\/2026\/10\/EN-ECU-IQVIA_FIFARMA_WAIT_2026_Country_Reports.pdf\"><div class=\"icon-left\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewbox=\"0 0 512 512\" class=\"gkit-icon\"><path d=\"M0 64C0 28.7 28.7 0 64 0H224V128c0 17.7 14.3 32 32 32H384V304H176c-35.3 0-64 28.7-64 64V512H64c-35.3 0-64-28.7-64-64V64zm384 64H256V0L384 128zM176 352h32c30.9 0 56 25.1 56 56s-25.1 56-56 56H192v32c0 8.8-7.2 16-16 16s-16-7.2-16-16V448 368c0-8.8 7.2-16 16-16zm32 80c13.3 0 24-10.7 24-24s-10.7-24-24-24H192v48h16zm96-80h32c26.5 0 48 21.5 48 48v64c0 26.5-21.5 48-48 48H304c-8.8 0-16-7.2-16-16V368c0-8.8 7.2-16 16-16zm32 128c8.8 0 16-7.2 16-16V400c0-8.8-7.2-16-16-16H320v96h16zm80-112c0-8.8 7.2-16 16-16h48c8.8 0 16 7.2 16 16s-7.2 16-16 16H448v32h32c8.8 0 16 7.2 16 16s-7.2 16-16 16H448v48c0 8.8-7.2 16-16 16s-16-7.2-16-16V432 368z\"\/><\/svg><\/div>Equador<\/a><\/div><\/div>\n \n\n \n<div data-block=\"gutenkit\/button\" data-post-id=\"9889\" id=\"block-f068be6a-8e4a-4a6a-83d8-5912f878e578\" class=\"wp-block-gutenkit-button gkit78e578 gutenkit-block\"><div class=\"gkit-btn-wraper\"><a class=\"gkit-btn\" href=\"https:\/\/fifarma.org\/wp-content\/uploads\/2026\/10\/EN-ARG-IQVIA_FIFARMA_WAIT_2026_Country_Reports.pdf\"><div class=\"icon-left\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewbox=\"0 0 512 512\" class=\"gkit-icon\"><path d=\"M0 64C0 28.7 28.7 0 64 0H224V128c0 17.7 14.3 32 32 32H384V304H176c-35.3 0-64 28.7-64 64V512H64c-35.3 0-64-28.7-64-64V64zm384 64H256V0L384 128zM176 352h32c30.9 0 56 25.1 56 56s-25.1 56-56 56H192v32c0 8.8-7.2 16-16 16s-16-7.2-16-16V448 368c0-8.8 7.2-16 16-16zm32 80c13.3 0 24-10.7 24-24s-10.7-24-24-24H192v48h16zm96-80h32c26.5 0 48 21.5 48 48v64c0 26.5-21.5 48-48 48H304c-8.8 0-16-7.2-16-16V368c0-8.8 7.2-16 16-16zm32 128c8.8 0 16-7.2 16-16V400c0-8.8-7.2-16-16-16H320v96h16zm80-112c0-8.8 7.2-16 16-16h48c8.8 0 16 7.2 16 16s-7.2 16-16 16H448v32h32c8.8 0 16 7.2 16 16s-7.2 16-16 16H448v48c0 8.8-7.2 16-16 16s-16-7.2-16-16V432 368z\"\/><\/svg><\/div>Argentina<\/a><\/div><\/div>\n <\/div>\n<\/div>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>","protected":false},"author":24,"parent":0,"template":"","ano":[187],"idioma":[45],"etiquetas-publicacion":[173,89],"categoria-publicacion":[29],"class_list":["post-9889","publicaciones","type-publicaciones","status-publish","hentry","ano-187","idioma-english","etiquetas-publicacion-wait","etiquetas-publicacion-wait-indicator","categoria-publicacion-reporte"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.2 (Yoast SEO v28.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>FIFARMA Patient W.A.I.T. Indicator 2026 (ENG)<\/title>\n<meta name=\"description\" content=\"FIFARMA W.A.I.T. Indicator 2026: Analysis of access to innovative medicines across 10 Latin American countries and 447 approved molecules.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fifarma.org\/pt\/publicacoes\/fifarma-patient-wait-indicator-2026\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FIFARMA Patient W.A.I.T. Indicator 2026 (ENG)\" \/>\n<meta property=\"og:description\" content=\"FIFARMA W.A.I.T. Indicator 2026: Analysis of access to innovative medicines across 10 Latin American countries and 447 approved molecules.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fifarma.org\/pt\/publicacoes\/fifarma-patient-wait-indicator-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"FIFARMA\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-05T01:55:10+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/fifarma-patient-wait-indicator-2026\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/fifarma-patient-wait-indicator-2026\\\/\",\"name\":\"FIFARMA Patient W.A.I.T. Indicator 2026 (ENG)\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\"},\"datePublished\":\"2026-07-28T03:29:13+00:00\",\"dateModified\":\"2026-11-05T01:55:10+00:00\",\"description\":\"FIFARMA W.A.I.T. Indicator 2026: Analysis of access to innovative medicines across 10 Latin American countries and 447 approved molecules.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/fifarma-patient-wait-indicator-2026\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/fifarma-patient-wait-indicator-2026\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/fifarma-patient-wait-indicator-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/fifarma.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Publicaciones\",\"item\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"FIFARMA Patient W.A.I.T. Indicator 2026 (ENG)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"name\":\"FIFARMA\",\"description\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"publisher\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fifarma.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\",\"name\":\"Fifarma\",\"alternateName\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"contentUrl\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"width\":195,\"height\":39,\"caption\":\"Fifarma\"},\"image\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"FIFARMA Patient W.A.I.T. Indicator 2026 (ENG)","description":"FIFARMA W.A.I.T. Indicator 2026: Analysis of access to innovative medicines across 10 Latin American countries and 447 approved molecules.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fifarma.org\/pt\/publicacoes\/fifarma-patient-wait-indicator-2026\/","og_locale":"pt_BR","og_type":"article","og_title":"FIFARMA Patient W.A.I.T. Indicator 2026 (ENG)","og_description":"FIFARMA W.A.I.T. Indicator 2026: Analysis of access to innovative medicines across 10 Latin American countries and 447 approved molecules.","og_url":"https:\/\/fifarma.org\/pt\/publicacoes\/fifarma-patient-wait-indicator-2026\/","og_site_name":"FIFARMA","article_modified_time":"2026-11-05T01:55:10+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. tempo de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fifarma.org\/publicaciones\/fifarma-patient-wait-indicator-2026\/","url":"https:\/\/fifarma.org\/publicaciones\/fifarma-patient-wait-indicator-2026\/","name":"FIFARMA Patient W.A.I.T. Indicator 2026 (ENG)","isPartOf":{"@id":"https:\/\/fifarma.org\/#website"},"datePublished":"2026-07-28T03:29:13+00:00","dateModified":"2026-11-05T01:55:10+00:00","description":"FIFARMA W.A.I.T. Indicator 2026: Analysis of access to innovative medicines across 10 Latin American countries and 447 approved molecules.","breadcrumb":{"@id":"https:\/\/fifarma.org\/publicaciones\/fifarma-patient-wait-indicator-2026\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fifarma.org\/publicaciones\/fifarma-patient-wait-indicator-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fifarma.org\/publicaciones\/fifarma-patient-wait-indicator-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/fifarma.org\/"},{"@type":"ListItem","position":2,"name":"Publicaciones","item":"https:\/\/fifarma.org\/publicaciones\/"},{"@type":"ListItem","position":3,"name":"FIFARMA Patient W.A.I.T. Indicator 2026 (ENG)"}]},{"@type":"WebSite","@id":"https:\/\/fifarma.org\/#website","url":"https:\/\/fifarma.org\/","name":"FIFARMA","description":"Federa\u00e7\u00e3o Latino-Americana da Ind\u00fastria Farmac\u00eautica","publisher":{"@id":"https:\/\/fifarma.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fifarma.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/fifarma.org\/#organization","name":"Fifarma","alternateName":"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica","url":"https:\/\/fifarma.org\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/","url":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","contentUrl":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","width":195,"height":39,"caption":"Fifarma"},"image":{"@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/publicaciones\/9889","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/publicaciones"}],"about":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/types\/publicaciones"}],"author":[{"embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/users\/24"}],"wp:attachment":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/media?parent=9889"}],"wp:term":[{"taxonomy":"ano","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/ano?post=9889"},{"taxonomy":"idioma","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/idioma?post=9889"},{"taxonomy":"etiquetas-publicacion","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/etiquetas-publicacion?post=9889"},{"taxonomy":"categoria-publicacion","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/categoria-publicacion?post=9889"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}